.jpg)
The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country.
Industry is gathering scientific data to approach the regulator, DCGI, for a review of the suspension order.
Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.
